Who owns RTI Biologics?

Key details on RTI Biologics (Ticker: RTIX)

Who owns RTI Biologics?

Is RTIX a good stock to own? Find out who bought RTI Biologics, who sold RTI Biologics (RTIX) stock, and who holds a large position in RTI Biologics.

Fund Name Number of Shares Share Valuation As Of
Paradigm Capital Management 4.85M $23.19M Sept. 30, 2014
DIMENSIONAL FUND ADVISORS 3.22M $15.38M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.83M $13.54M Sept. 30, 2014
HILLMAN 2.68M $13.95M Dec. 31, 2014
Tamarack Capital Management 2.20M $10.52M Sept. 30, 2014
KOPP FUNDS 2.17M $7.67M Dec. 31, 2013
GAGNON SECURITIES 1.94M $9.29M Sept. 30, 2014
Royce & Associates 1.91M $9.12M Sept. 30, 2014
Rock Springs Capital Management 1.86M $8.89M Sept. 30, 2014
Kopp Investment Advisors 1.81M $8.66M Sept. 30, 2014
Frank Russell Company 1.62M $7.74M Sept. 30, 2014
Vanguard 1.59M $7.59M Sept. 30, 2014
Fort Washington Investment Advisors 1.58M $5.92M June 30, 2013
Signia Capital Management 1.50M $5.91M March 31, 2013
Millennium Management 1.40M $5.71M March 31, 2014
BlackRock Fund Advisors 1.35M $6.43M Sept. 30, 2014
First Light Asset Management 1.34M $6.40M Sept. 30, 2014
STATE STREET CORPORATION 1.21M $5.16M Dec. 31, 2013
JPMORGAN CHASE & CO 1.10M $4.12M June 30, 2012
Principal Financial 1.09M $4.63M Dec. 31, 2012
NorthPointe Capital 1.04M $3.85M March 31, 2012

Who sold RTI Biologics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Accipiter Capital Management June 30, 2011 1.75M $4.74M
Manulife Asset Management June 30, 2011 1.42M $3.84M
FMR Dec. 31, 2010 8.21M $21.92M
Cortina Asset Management Dec. 31, 2010 1.08M $2.89M